Certified by Founder Lodge
XyloCor Therapeutics, Inc.
United States - King of Prussia, Pennsylvania
START UP
1 Disclosed Funding Rounds $67,500,000
0 Participating Investments
-
Founded date
2013
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 09 ,2025 | Series B | $67,500,000 |
Lumira Ventures
JEITO
Fountain Healthcare Partners
Knit
CHARM Therapeutics
Curebase
SLAMcore Limited
Anthropic
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
